The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 29, 2017

Filed:

Apr. 22, 2014
Applicants:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Merck Canada Inc., Kirkland, CA;

Inventors:

Neville J. Anthony, Northborough, MA (US);

Brian M. Andresen, Sharon, MA (US);

Alan B. Northrup, Reading, MA (US);

Kaleen K. Childers, Newton, MA (US);

Anthony Donofrio, Cambridge, MA (US);

Thomas A. Miller, Wakefield, MA (US);

Yuan Liu, Belmont, MA (US);

Michelle R. Machacek, Brookline, MA (US);

Hyun Chong Woo, Natick, MA (US);

Kerrie B. Spencer, Woonsocket, RI (US);

John Michael Ellis, Needham, MA (US);

Michael D. Altman, Needham, MA (US);

Eric T. Romeo, Allston, MA (US);

Daniel Guay, Lachine, CA;

Jonathan Grimm, Ashburn, VA (US);

Marie-Eve Lebrun, Dollard-des-Ormeaux, CA;

Joel S. Robichaud, Dollard-des-Ormeaux, CA;

Liping Wang, Dayton, NJ (US);

Byron DuBois, New York, NY (US);

Qiaolin Deng, Edison, NJ (US);

Assignees:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Merck Canada Inc., Karkland, Province of Quebec, CA;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4439 (2006.01); A61K 31/53 (2006.01); A61K 31/501 (2006.01); A61K 31/497 (2006.01); A61K 31/506 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01);
U.S. Cl.
CPC ...
C07D 417/14 (2013.01); A61K 31/4439 (2013.01); A61K 31/497 (2013.01); A61K 31/501 (2013.01); A61K 31/506 (2013.01); A61K 31/53 (2013.01); C07D 417/12 (2013.01);
Abstract

The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein X, X, X, X, Y, Y, Y, Y, and Rare as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).


Find Patent Forward Citations

Loading…